{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:49:02Z","timestamp":1793994542197,"version":"4.8.0"},"reference-count":250,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["BT\/PR6490\/GBD\/27\/429"],"award-info":[{"award-number":["BT\/PR6490\/GBD\/27\/429"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-10-BS-04"],"award-info":[{"award-number":["1-10-BS-04"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbamem.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T22:59:34Z","timestamp":1520290774000},"page":"1765-1782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies"],"prefix":"10.1016","volume":"1860","author":[{"given":"Shreyasi","family":"Asthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibekanand","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei T.","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2018.02.020_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0015","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00251821","article-title":"Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin","volume":"24","author":"Westermark","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0025","first-page":"291","article-title":"The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults","volume":"81","author":"Westermark","year":"1973","journal-title":"Acta Pathol. Microbiol. Scand. A Pathol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","article-title":"Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?","volume":"53","author":"Zraika","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0040","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/S0021-9258(19)39539-0","article-title":"Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits","volume":"265","author":"Nishi","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0045","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1110\/ps.036350.108","article-title":"Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin","volume":"17","author":"Knight","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0055","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1038\/srep08240","article-title":"Inhibition of IAPP aggregation by insulin depends on the insulin oligomeric state regulated by zinc ion concentration","volume":"5","author":"Nedumpully-Govindan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00400929","article-title":"Islet amyloid polypeptide immunoreactivity in the human fetal pancreas","volume":"35","author":"P.A. In 't Veld","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0014-5793(90)80314-9","article-title":"The human islet amyloid polypeptide (IAPP) gene: organization, chromosomal localization and functional identification of a promoter region","volume":"267","author":"Christmanson","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0167-4781(90)90210-S","article-title":"Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man","volume":"1087","author":"Van Mansfeld","year":"1990","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0075","doi-asserted-by":"crossref","first-page":"11986","DOI":"10.1074\/jbc.272.18.11986","article-title":"Identification of cis-and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic \u03b2-cells","volume":"272","author":"Carty","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0080","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.1074\/jbc.M908045199","article-title":"Glucose regulates islet amyloid polypeptide gene transcription in a PDX1-and calcium-dependent manner","volume":"275","author":"Macfarlane","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0085","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1152\/ajpendo.2001.281.5.E938","article-title":"Glucose and forskolin regulate IAPP gene expression through different signal transduction pathways","volume":"281","author":"Ding","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0090","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00242.2009","article-title":"Fatty acids induce amylin expression and secretion by pancreatic \u03b2-cells","volume":"298","author":"Qi","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019559","article-title":"MCP-1 upregulates amylin expression in murine pancreatic \u03b2 cells through ERK\/JNK-AP1 and NF-\u03baB related signaling pathways independent of CCR2","volume":"6","author":"Cai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00125-010-1972-9","article-title":"TNF-\u03b1 acutely upregulates amylin expression in murine pancreatic beta cells","volume":"54","author":"Cai","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0105","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1096\/fj.15-270553","article-title":"Islet amyloid polypeptide exerts a novel autocrine action in \u03b2-cell signaling and proliferation","volume":"29","author":"Visa","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0115","doi-asserted-by":"crossref","first-page":"11807","DOI":"10.1074\/jbc.M113.525022","article-title":"Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through MIR-124A and FOXA2","volume":"289","author":"Jing","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/MPA.0b013e3181d12613","article-title":"Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition","volume":"39","author":"Zhao","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0125","series-title":"Protein Misfolding Diseases: Current and Emerging Principles and Therapies","first-page":"517","article-title":"Islet amyloid polypeptide","author":"Abedini","year":"2010"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0135","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1046\/j.1432-1327.2000.01548.x","article-title":"Processing of synthetic pro-islet amyloid polypeptide (proIAPP)\u2018amylin\u2019by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro","volume":"267","author":"Higham","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.bbamem.2018.02.020_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2990001","article-title":"Sorting and processing of secretory proteins","volume":"299","author":"Halban","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0145","first-page":"39","article-title":"The role of islet amyloid polypeptide in type 2 diabetes","volume":"28","author":"Marzban","year":"2004","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0150","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1016\/S0021-9258(19)77825-9","article-title":"An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing","volume":"263","author":"Sanke","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0155","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","article-title":"Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus","volume":"86","author":"Roberts","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0160","first-page":"234A","article-title":"Heterogeneity of naturally-occurring human amylin due to glycosylation","volume":"45","author":"Rittenhouse","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1463-1326.2012.01657.x","article-title":"Metabolic stress, IAPP and islet amyloid","volume":"14","author":"Montane","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0170","first-page":"2822","article-title":"Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes","volume":"85","author":"Makimattila","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0175","article-title":"Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0180","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1002\/chem.201303303","article-title":"Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists","volume":"19","author":"Tomabechi","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0185","first-page":"203","article-title":"Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes","volume":"2","author":"Ryan","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0190","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1074\/jbc.M809085200","article-title":"Dynamic alpha-helix structure of micelle-bound human amylin","volume":"284","author":"Patil","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0195","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1073\/pnas.86.15.5738","article-title":"Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone","volume":"86","author":"Nishi","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","article-title":"Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species","volume":"251","author":"Betsholtz","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0205","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/eje.0.1330017","article-title":"Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions","volume":"133","author":"Muff","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2014.01.013","article-title":"Amylin activates distributed CNS nuclei to control energy balance","volume":"136","author":"Mietlicki-Baase","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0220","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1152\/ajpendo.1998.275.3.E531","article-title":"Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle","volume":"275","author":"Castle","year":"1998","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1748-1716.1990.tb08861.x","article-title":"Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats","volume":"138","author":"Pettersson","year":"1990","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0230","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0006-291X(91)90628-K","article-title":"Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets","volume":"177","author":"Broderick","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0235","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1152\/ajpendo.2001.280.3.E443","article-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","volume":"280","author":"Silvestre","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(05)52008-8","article-title":"Inhibition of glucagon secretion","volume":"52","author":"Young","year":"2004","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"Akesson","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0250","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1523\/JNEUROSCI.2764-04.2004","article-title":"Extracellular signal-regulated kinase 1\/2 signaling pathway in solitary nucleus mediates cholecystokinin-induced suppression of food intake in rats","volume":"24","author":"Sutton","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2012.01670.x","article-title":"The interaction of amylin with other hormones in the control of eating","volume":"15","author":"Lutz","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0260","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0265","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bone.2008.07.003","article-title":"The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism","volume":"43","author":"Naot","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0275","series-title":"IDF Diabetes Atlas","author":"I.D. Federation","year":"2017"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0280","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmb.2011.12.032","article-title":"Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20","volume":"421","author":"Cao","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0295","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/13506120108993820","article-title":"Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide","volume":"8","author":"Ma","year":"2001","journal-title":"Amyloid"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0300","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00125-003-1068-x","article-title":"Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori","volume":"46","author":"Poa","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0305","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/prot.24795","article-title":"Complete characterization of the mutation landscape reveals the effect on amylin stability and amyloidogenicity","volume":"83","author":"Smaoui","year":"2015","journal-title":"Proteins"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0310","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0002-9440(10)64848-1","article-title":"S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin","volume":"157","author":"Sakagashira","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047150","article-title":"Conformations of islet amyloid polypeptide monomers in a membrane environment: implications for fibril formation","volume":"7","author":"Duan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0320","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1084\/jem.20161134","article-title":"Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism","volume":"214","author":"Mukherjee","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0325","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0335","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1021\/bi020314u","article-title":"Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes","volume":"41","author":"Anguiano","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00125-011-2338-7","article-title":"cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets","volume":"55","author":"Subramanian","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","article-title":"Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis","volume":"52","author":"Zraika","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0350","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","article-title":"Mechanisms of islet amyloidosis toxicity in type 2 diabetes","volume":"587","author":"Abedini","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","article-title":"Protein glycation, diabetes, and aging","volume":"56","author":"Ulrich","year":"2000","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0370","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/138161208784139701","article-title":"Advanced glycation end products (AGEs) and their involvement in liver disease","volume":"14","author":"Hyogo","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ncpendmet0786","article-title":"Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications","volume":"4","author":"Yan","year":"2008","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0380","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1432-1327.1998.2510208.x","article-title":"Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide","volume":"251","author":"Kapurniotu","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0385","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jmb.2009.04.077","article-title":"Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes","volume":"389","author":"Jha","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0390","doi-asserted-by":"crossref","first-page":"22894","DOI":"10.1074\/jbc.M110.215814","article-title":"Mechanism of amylin fibrillization enhancement by heparin","volume":"286","author":"Jha","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0395","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0026-0495(97)90209-2","article-title":"Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents","volume":"46","author":"Gulli","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0400","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pneurobio.2017.03.001","article-title":"Islet amyloid polypeptide: another key molecule in Alzheimer's pathogenesis?","volume":"153","author":"Zhang","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0405","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats","volume":"110","author":"Despa","year":"2012","journal-title":"Circ. Res."},{"issue":"35","key":"10.1016\/j.bbamem.2018.02.020_bb0410","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.774893","article-title":"Key aromatic\/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly","volume":"295","author":"Bakou","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0415","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/anie.201105877","article-title":"Cross-amyloid interaction of Abeta and IAPP at lipid membranes","volume":"51","author":"Seeliger","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0425","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"Gong","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0430","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/db16-0044","article-title":"Hyperamylinemia increases IL-1beta synthesis in the heart via peroxidative sarcolemmal injury","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001015","article-title":"Cardioprotection by controlling hyperamylinemia in a \"humanized\" diabetic rat model","volume":"3","author":"Despa","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: history of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0445","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0450","doi-asserted-by":"crossref","first-page":"16863","DOI":"10.1073\/pnas.1002867107","article-title":"Protein-induced photophysical changes to the amyloid indicator dye thioflavin T","volume":"107","author":"Wolfe","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0455","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/labinvest.3700714","article-title":"Physical basis of colors seen in Congo red-stained amyloid in polarized light","volume":"88","author":"Howie","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0460","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0465","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jmb.2009.09.039","article-title":"The common architecture of cross-beta amyloid","volume":"395","author":"Jahn","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0470","series-title":"Protein Misfolding","article-title":"NMR of amyloidogenic proteins","author":"Alexandrescu","year":"2008"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-biochem-061516-045104","article-title":"Structural studies of amyloid proteins at the molecular level","volume":"86","author":"Eisenberg","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0480","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0076-6879(09)66010-9","article-title":"Electrostatic contributions to the stabilities of native proteins and amyloid complexes","volume":"466","author":"Sheftic","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0485","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0022-2836(85)90175-5","article-title":"Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism","volume":"183","author":"Ferrone","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0490","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0495","doi-asserted-by":"crossref","first-page":"pe43","DOI":"10.1126\/scisignal.280pe43","article-title":"Functional amyloids signal their arrival","volume":"2","author":"Badtke","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0500","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1173155","article-title":"Functional amyloids as natural storage of peptide hormones in pituitary secretory granules","volume":"325","author":"Maji","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060195","article-title":"Bacterial inclusion bodies contain amyloid-like structure","volume":"6","author":"Wang","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0510","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1002\/anie.200703133","article-title":"Amyloids: not only pathological agents but also ordered nanomaterials","volume":"47","author":"Cherny","year":"2008","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0515","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1039\/C4CS00082J","article-title":"Amyloid-based nanosensors and nanodevices","volume":"43","author":"Hauser","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0520","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/bi5011442","article-title":"Peptide amyloid surface display","volume":"54","author":"Rubio","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0525","series-title":"Chemistry","article-title":"The amyloidogenic propensity of human proislet amyloid polypeptide in the presence of lipids","author":"Jha","year":"2009"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0530","doi-asserted-by":"crossref","first-page":"30585","DOI":"10.1074\/jbc.M112.375345","article-title":"A generic crystallization-like model that describes the kinetics of amyloid fibril formation","volume":"287","author":"Crespo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0535","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0022-2836(85)90174-3","article-title":"Kinetics of sickle hemoglobin polymerization. I. Studies using temperature-jump and laser photolysis techniques","volume":"183","author":"Ferrone","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0540","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0076-6879(86)30007-7","article-title":"The measurement of cooperative protein self-assembly by turbidity and other techniques","volume":"130","author":"Andreu","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0545","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.289.5483.1317","article-title":"Nucleated conformational conversion and the replication of conformational information by a prion determinant","volume":"289","author":"Serio","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0550","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M109541200","article-title":"Biophysical properties of the synucleins and their propensities to fibrillate inhibition of \u03b1-synuclein assembly by \u03b2-and \u03b3-synucleins","volume":"277","author":"Uversky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0555","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1021\/bi0160462","article-title":"Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis","volume":"41","author":"Padrick","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0560","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1021\/bi101908m","article-title":"Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy","volume":"50","author":"Patil","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0565","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"elife"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0570","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1074\/jbc.M110.166678","article-title":"The molecular basis of distinct aggregation pathways of islet amyloid polypeptide","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0575","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0580","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","article-title":"Fibril structure of human islet amyloid polypeptide","volume":"287","author":"Bedrood","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0585","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1002\/smll.201500562","article-title":"Nanoscale heterogeneity of the molecular structure of individual hIAPP amyloid fibrils revealed with tip-enhanced Raman spectroscopy","volume":"11","author":"vandenAkker","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0590","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature03986","article-title":"Molecular recycling within amyloid fibrils","volume":"436","author":"Carulla","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2009.03.008","article-title":"Membrane permeabilization by Islet Amyloid Polypeptide","volume":"160","author":"Engel","year":"2009","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0600","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0605","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature05290","article-title":"A century-old debate on protein aggregation and neurodegeneration enters the clinic","volume":"443","author":"Lansbury","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0610","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1021\/bi702518m","article-title":"Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death","volume":"47","author":"Meng","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0615","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","article-title":"Amyloid ion channels: a common structural link for protein-misfolding disease","volume":"102","author":"Quist","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0630","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0708354105","article-title":"Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane","volume":"105","author":"Engel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0635","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1042\/BST0361293","article-title":"Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease","volume":"36","author":"Allsop","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0640","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/diab.43.2.329","article-title":"Islet amyloid polypeptide in human insulinomas: evidence for intracellular amyloidogenesis","volume":"43","author":"O'Brien","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0645","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00125-006-0206-7","article-title":"Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets","volume":"49","author":"Paulsson","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0650","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0655","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/bi800828u","article-title":"Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical states","volume":"47","author":"Yonemoto","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0660","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s00125-011-2143-3","article-title":"Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets","volume":"54","author":"Aston-Mourney","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0665","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.chembiol.2009.08.013","article-title":"A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes","volume":"16","author":"Hebda","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0670","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (\u03b1)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0675","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1021\/cr400525m","article-title":"Classification of intrinsically disordered regions and proteins","volume":"114","author":"van der Lee","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0680","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biocel.2011.04.001","article-title":"Intrinsically disordered proteins from A to Z","volume":"43","author":"Uversky","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0685","first-page":"89","article-title":"The protein non-folding problem: amino acid determinants of intrinsic order and disorder","author":"Mathura","year":"2001","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0690","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1074\/jbc.M801383200","article-title":"Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding","volume":"283","author":"Apostolidou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0695","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.bbamem.2011.06.012","article-title":"Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment","volume":"1808","author":"Nanga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0700","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1021\/ja9010095","article-title":"Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy","volume":"131","author":"Nanga","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0705","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzp029","article-title":"Solution state structures of human pancreatic amylin and pramlintide","volume":"22","author":"Cort","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003211","article-title":"Structural similarities and differences between amyloidogenic and non-amyloidogenic islet amyloid polypeptide (IAPP) sequences and implications for the dual physiological and pathological activities of these peptides","volume":"9","author":"Wu","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0715","doi-asserted-by":"crossref","DOI":"10.1038\/srep44041","article-title":"The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes","volume":"7","author":"Rodriguez Camargo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0720","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31226","article-title":"Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate","volume":"6","author":"Rodriguez Camargo","year":"2017","journal-title":"elife"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0725","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1110\/ps.036509.108","article-title":"Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin)","volume":"17","author":"Wiltzius","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0730","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmb.2005.02.029","article-title":"The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin","volume":"348","author":"Kajava","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0735","doi-asserted-by":"crossref","first-page":"19285","DOI":"10.1073\/pnas.1314481110","article-title":"Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient beta-sheet","volume":"110","author":"Buchanan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0740","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1021\/ja204035k","article-title":"2DIR spectroscopy of human amylin fibrils reflects stable beta-sheet structure","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056467","article-title":"Amide proton solvent protection in amylin fibrils probed by quenched hydrogen exchange NMR","volume":"8","author":"Alexandrescu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0750","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.bpj.2009.08.041","article-title":"Evidence for a partially structured state of the amylin monomer","volume":"97","author":"Vaiana","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0755","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1021\/jp100205w","article-title":"Effect of the disulfide bond on the monomeric structure of human amylin studied by combined Hamiltonian and temperature replica exchange molecular dynamics simulations","volume":"114","author":"Laghaei","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0760","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/6\/1\/015005","article-title":"A role for helical intermediates in amyloid formation by natively unfolded polypeptides?","volume":"6","author":"Abedini","year":"2009","journal-title":"Phys. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0765","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s13361-016-1347-7","article-title":"Human islet amyloid polypeptide N-terminus fragment self-assembly: effect of conserved disulfide bond on aggregation propensity","volume":"27","author":"Ilitchev","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0770","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/c3cc38982k","article-title":"Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization","volume":"49","author":"Sri Vaishnavi","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0775","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmb.2005.10.052","article-title":"Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?","volume":"355","author":"Abedini","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1110\/ps.04887005","article-title":"Amyloid accomplices and enforcers","volume":"14","author":"Alexandrescu","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0785","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0167-4838(92)90411-6","article-title":"Promotion of \u03b2-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine","volume":"1122","author":"McLean","year":"1992","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0790","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","article-title":"Pore formation by the cytotoxic islet amyloid peptide amylin","volume":"271","author":"Mirzabekov","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0795","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0800","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","article-title":"Phospholipid catalysis of diabetic amyloid assembly","volume":"341","author":"Knight","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0805","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acs.biochem.6b01016","article-title":"Islet amyloid polypeptide membrane interactions: effects of membrane composition","volume":"56","author":"Zhang","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0810","doi-asserted-by":"crossref","first-page":"12113","DOI":"10.1021\/bi050840w","article-title":"Lipid membranes modulate the structure of islet amyloid polypeptide","volume":"44","author":"Jayasinghe","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0815","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02538912","article-title":"Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells","volume":"29","author":"Rustenbeck","year":"1994","journal-title":"Lipids"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0820","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpj.2010.09.070","article-title":"Biphasic effects of insulin on islet amyloid polypeptide membrane disruption","volume":"100","author":"Brender","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0825","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ar200189b","article-title":"Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective","volume":"45","author":"Brender","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0830","doi-asserted-by":"crossref","first-page":"19279","DOI":"10.1073\/pnas.1305517110","article-title":"Islet amyloid polypeptide toxicity and membrane interactions","volume":"110","author":"Cao","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0835","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bpj.2016.05.050","article-title":"The role of cholesterol in driving IAPP-membrane interactions","volume":"111","author":"Sciacca","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0840","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1021\/bi060579z","article-title":"Conserved and cooperative assembly of membrane-bound \u03b1-helical states of islet amyloid polypeptide","volume":"45","author":"Knight","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0845","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-319-17344-3_4","article-title":"Role of cholesterol and phospholipids in amylin misfolding, aggregation and etiology of islet amyloidosis","volume":"855","author":"Singh","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0850","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00125-016-3907-6","article-title":"ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice","volume":"59","author":"Wijesekara","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:10:1:1","article-title":"Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease","volume":"10","author":"Levy","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0860","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.abb.2008.06.018","article-title":"Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus","volume":"477","author":"Sciacca","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0865","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpj.2012.11.3811","article-title":"Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP","volume":"104","author":"Sciacca","year":"2013","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0870","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/ja809002a","article-title":"Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide","volume":"131","author":"Smith","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0875","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.1991.71.2.481","article-title":"Glycosaminoglucans: molecular properties, protein interactions, and role in physiological processes","volume":"71","author":"Jackson","year":"1991","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0880","first-page":"951","article-title":"Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus","volume":"116","author":"Young","year":"1992","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0885","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1937-6448(09)76003-4","article-title":"Interactions between heparan sulfate and proteins-design and functional implications","volume":"276","author":"Lindahl","year":"2009","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0890","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/bi011711s","article-title":"Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from \u03b1-synuclein in vitro","volume":"41","author":"Cohlberg","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0895","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2741\/A277","article-title":"Alzheimer's disease and heparan sulfate proteoglycan","volume":"3","author":"Fukuchi","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0900","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000049037","article-title":"Affinity binding of glycosaminoglycans with beta-2-microglobulin","volume":"90","author":"Ohashi","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0905","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1523-1755.2003.00167.x","article-title":"Glycosaminoglycan and proteoglycan inhibit the depolymerization of &bgr; 2-microglobulin amyloid fibrils in vitro","volume":"64","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0910","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.25011\/cim.v30i4.2870","article-title":"Heparin induces amyloid formation in cultured human islets","volume":"30","author":"Potter","year":"2007","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0915","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diabetes.47.4.612","article-title":"Sulfate content and specific glycosaminoglycan backbone of Perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation","volume":"47","author":"Castillo","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0920","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1471-4159.1999.721681.x","article-title":"The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation","volume":"72","author":"Castillo","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0925","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0003-9861(03)00116-4","article-title":"Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin","volume":"413","author":"Potter-Perigo","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0930","doi-asserted-by":"crossref","first-page":"15121","DOI":"10.1074\/jbc.M114.631697","article-title":"Heparan sulfate proteoglycans are important for islet amyloid formation and islet amyloid polypeptide-induced apoptosis","volume":"290","author":"Oskarsson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0935","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ajt.13134","article-title":"Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase","volume":"15","author":"Potter","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0940","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/glycob\/cwp205","article-title":"Heparan sulfate mediates amyloid-beta internalization and cytotoxicity","volume":"20","author":"Sandwall","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0945","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1021\/bi0510936","article-title":"Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation","volume":"45","author":"Abedini","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0950","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","article-title":"Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide implications for amyloid formation","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0955","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano\u2013bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0960","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1073\/pnas.0701250104","article-title":"Nucleation of protein fibrillation by nanoparticles","volume":"104","author":"Linse","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0965","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.1073\/pnas.0703194104","article-title":"Nanoparticles as catalysts for protein fibrillation","volume":"104","author":"Colvin","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0970","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinorgbio.2015.08.020","article-title":"Effects of gold complexes on the assembly behavior of human islet amyloid polypeptide","volume":"152","author":"He","year":"2015","journal-title":"J. Inorg. Biochem."},{"issue":"3","key":"10.1016\/j.bbamem.2018.02.020_bb0975","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1039\/C6BM00764C","article-title":"Differential effects of silver and iron oxide nanoparticles on IAPP amyloid aggregation","volume":"5","author":"Wang","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0980","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/la902980d","article-title":"Inhibition of IAPP and IAPP (20\u221229) fibrillation by polymeric nanoparticles","volume":"26","author":"Cabaleiro-Lago","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0985","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/smll.201502317","article-title":"Inhibition of hIAPP Amyloid Aggregation and Pancreatic \u03b2\u2010Cell Toxicity by OH\u2010Terminated PAMAM Dendrimer","volume":"12","author":"Gurzov","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.bbamem.2018.02.020_bb0990","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1039\/C5CP05924K","article-title":"Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells","volume":"18","author":"Nedumpully-Govindan","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbamem.2018.02.020_bb0995","article-title":"Exploring the influence of carbon nanoparticles on the formation of \u03b2-sheet-rich oligomers of IAPP 22\u201328 peptide by molecular dynamics simulation","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1000","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ppsc.201400222","article-title":"Structure-making effects of metal nanoparticles in amyloid peptide fibrillation","volume":"32","author":"Gladytz","year":"2015","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/pro.2023","article-title":"Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers","volume":"21","author":"Noor","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/bi401164k","article-title":"The pH-dependence of amylin fibrillization","volume":"53","author":"Jha","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1015","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/cbic.200800052","article-title":"The fluorescent amino acid p-cyanophenylalanine provides an intrinsic probe of amyloid formation","volume":"9","author":"Marek","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/bi501016r","article-title":"Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions","volume":"54","author":"Tu","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1025","article-title":"Charge-based inhibitors of amylin fibrillization and toxicity","volume":"2015","author":"Patil","year":"2015","journal-title":"Diabetes Res."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1030","article-title":"Living cell microarrays: an overview of concepts","volume":"5","author":"Jonczyk","year":"2016","journal-title":"Microarrays (Basel)"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1096\/fj.11-194613","article-title":"Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide","volume":"26","author":"Magzoub","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors","volume":"7","author":"Klabunde","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1045","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/chem.201303928","article-title":"Synthesis of 2,5-diaryl-substituted thiophenes as helical mimetics: towards the modulation of islet amyloid polypeptide (IAPP) amyloid fibril formation and cytotoxicity","volume":"20","author":"Hassanpour","year":"2014","journal-title":"Chemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00249-012-0846-0","article-title":"Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper","volume":"41","author":"Sheftic","year":"2012","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1055","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11412","article-title":"Foldamer-mediated manipulation of a pre-amyloid toxin","volume":"7","author":"Kumar","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1060","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1016\/j.biomaterials.2014.06.056","article-title":"Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1065","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1021\/bi051432v","article-title":"The role of His-18 in amyloid formation by human islet amyloid polypeptide","volume":"44","author":"Abedini","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1070","article-title":"Acidic pH retards the fibrillization of human Islet Amyloid Polypeptide due to electrostatic repulsion of histidines","volume":"139","author":"Li","year":"2013","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1075","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/ja1007867","article-title":"Role of zinc in human islet amyloid polypeptide aggregation","volume":"132","author":"Brender","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1080","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1021\/acs.biochem.5b00891","article-title":"Promotion or inhibition of islet amyloid polypeptide aggregation by zinc coordination depends on its relative concentration","volume":"54","author":"Nedumpully-Govindan","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"Larson","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1090","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jff.2014.12.013","article-title":"Inhibition of toxic IAPP amyloid by extracts of common fruits","volume":"12","author":"Kao","year":"2015","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1095","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/bi2015162","article-title":"Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols","volume":"51","author":"Cao","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1100","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/ja3115696","article-title":"Toward the molecular mechanism (s) by which EGCG treatment remodels mature amyloid fibrils","volume":"135","author":"Palhano","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1105","article-title":"Exploring the influence of EGCG on the \u03b2-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1\u201337) and identifying its possible binding sites from molecular dynamics simulation","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1110","doi-asserted-by":"crossref","DOI":"10.1038\/srep19463","article-title":"Stabilizing off-pathway oligomers by polyphenol nanoassemblies for IAPP aggregation inhibition","volume":"6","author":"Nedumpully-Govindan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/13506129.2010.530008","article-title":"The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity","volume":"17","author":"Daval","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbrc.2012.05.013","article-title":"Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling \u03b1-helix","volume":"422","author":"Sparks","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1125","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.febslet.2009.03.059","article-title":"Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol","volume":"583","author":"Radovan","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1130","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bpj.2011.02.010","article-title":"Resveratrol inhibits the formation of multiple-layered \u03b2-sheet oligomers of the human islet amyloid polypeptide segment 22\u201327","volume":"100","author":"Jiang","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1135","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1021\/ja8097417","article-title":"Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study","volume":"131","author":"Evers","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1140","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/anie.200705372","article-title":"Small-molecule inhibitors of islet amyloid polypeptide fibril formation","volume":"47","author":"Mishra","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1145","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1021\/jf201702h","article-title":"Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus","volume":"59","author":"Cheng","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1150","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jnutbio.2009.04.010","article-title":"Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin","volume":"21","author":"Rigacci","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/prot.24216","article-title":"Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptideand protects pancreatic beta cells against cytotoxicity","volume":"81","author":"Cheng","year":"2013","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1160","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fct.2013.02.049","article-title":"Proanthocyanidins are the major anti-diabetic components of cinnamon water extract","volume":"56","author":"Jiao","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","article-title":"Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation","volume":"226","author":"Soto","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1170","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1175","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/acs.biochem.5b00567","article-title":"Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity","volume":"54","author":"Wang","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","article-title":"Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis","volume":"318","author":"Scrocchi","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1185","doi-asserted-by":"crossref","first-page":"23545","DOI":"10.1074\/jbc.M116.742460","article-title":"Inhibition of insulin amyloid fibrillation by a novel amphipathic heptapeptide: mechanistic details studied by spectroscopy in combination with microscopy","volume":"291","author":"Ratha","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1190","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.febslet.2014.02.020","article-title":"A hIAPP-derived all-D-amino-acid inhibits hIAPP fibrillation efficiently at membrane surface by targeting alpha-helical oligomeric intermediates","volume":"588","author":"Wang","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1205","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jmb.2012.02.007","article-title":"Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates","volume":"421","author":"Saridaki","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1215","first-page":"C1586","article-title":"Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro","volume":"293","author":"Hull","year":"2007","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2010.12.028","article-title":"Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates","volume":"406","author":"Meng","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1225","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1039\/c3cc41452c","article-title":"A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide","volume":"49","author":"Kumar","year":"2013","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.bbamem.2018.02.020_bb1230","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1021\/ja3031664","article-title":"The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution","volume":"134","author":"Engel","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1235","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nrn938","article-title":"Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning","volume":"3","author":"Schenk","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1240","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1074\/jbc.M115.682336","article-title":"Design and optimization of anti-amyloid domain antibodies specific for beta-amyloid and islet amyloid polypeptide","volume":"291","author":"Lee","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1245","doi-asserted-by":"crossref","first-page":"34156","DOI":"10.1074\/jbc.M102883200","article-title":"Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation","volume":"276","author":"Azriel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1250","first-page":"67","article-title":"An NMR-based quenched hydrogen exchange investigation of model amyloid fibrils formed by cold shock protein A","author":"Alexandrescu","year":"2001","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-2978-8_14","article-title":"Quenched hydrogen exchange NMR of amyloid fibrils","volume":"1345","author":"Alexandrescu","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1260","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1749-6632.1997.tb48485.x","article-title":"\u201cAmyloid is not a tombstone\u201d\u2014a summation. The primary role for cerebrovascular and CSF dynamics as factors in Alzheimer's disease (AD): DMSO, fluorocarbon oxygen carriers, thyroid hormonal, and other suggested therapeutic measures","volume":"826","author":"Regelson","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbamem.2018.02.020_bb1265","doi-asserted-by":"crossref","first-page":"14340","DOI":"10.1021\/ja1046186","article-title":"Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation","volume":"132","author":"Meng","year":"2010","journal-title":"J. Am. Chem. Soc."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273618300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273618300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T08:47:27Z","timestamp":1757753247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273618300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":250,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0005273618300610"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2018.02.020","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}